Status:

NOT_YET_RECRUITING

The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer

Lead Sponsor:

University of Arizona

Conditions:

Lung Cancer - Non Small Cell

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

There is increased interest and knowledge about the lung cancer tumor microenvironment (TME). Investigators hypothesize that patients with better baseline physiologic health will have better post-oper...

Detailed Description

Background Lung cancer continues to be the most common cause of cancer related death in both men and women. Patients have variable responses to treatment, whether they receive neoadjuvant therapy or ...

Eligibility Criteria

Inclusion

  • lung cancer
  • low risk for submaximal exercise testing in accordance with the risk stratification guidelines published by the American Heart Association and the American College of Sports Medicine (AHA/ACSM criteria).

Exclusion

  • younger than 18 years of age
  • select a condition on the ACSM-AHA pre-exercise screening questionnaire indicating that physician approval is required prior to exercise
  • body mass index of \>30 kg/m2
  • waist girth of \>102cm for men and \>88cm for women
  • have chronic/debilitating arthritis
  • have been bedridden in the past three months
  • have common illness (i.e. colds) within the past 6-weeks
  • HIV
  • hepatitis
  • history of stroke
  • major affective disorder
  • autoimmune disease
  • pregnancy or are breast-feeding
  • history of severe anaphylactic reaction to an allergen
  • present with more than one of the following CVD risk factors: family history of myocardial infarction, coronary revascularization, or sudden death before 55 years of age in father or other male first-degree relative or before 65 years of age in mother or other female first-degree relative

Key Trial Info

Start Date :

November 20 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 15 2030

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT07216209

Start Date

November 20 2025

End Date

January 15 2030

Last Update

October 22 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Arizona Cancer Center

Tucson, Arizona, United States, 85719